BeOne Medicines AG (ONC)
NASDAQ: ONC · Real-Time Price · USD
279.99
+4.65 (1.69%)
At close: Jun 26, 2026, 4:00 PM EDT
279.89
-0.10 (-0.04%)
After-hours: Jun 26, 2026, 4:10 PM EDT
BeOne Medicines AG Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 513.02 | 286.93 | -644.79 | -881.71 | -2,004 | -1,458 |
Depreciation & Amortization | 150.03 | 141.69 | 171.76 | 87.68 | 66.28 | 46.46 |
Stock-Based Compensation | 538.73 | 510.86 | 441.62 | 367.62 | 303.16 | 240.71 |
Other Adjustments | -118.64 | -2.79 | 47.94 | -360.5 | 5.37 | -9.73 |
Change in Receivables | -208.39 | -164.95 | -329.44 | -188.31 | 304.11 | -423.02 |
Changes in Inventories | -168.99 | -93.17 | -91.5 | -140.95 | -56.69 | -153.33 |
Changes in Accounts Payable | 69.21 | 79.83 | 121.5 | 21.48 | -4.35 | 20.01 |
Changes in Accrued Expenses | 347.3 | 311.76 | 111.35 | 180.11 | 45.63 | 140.04 |
Changes in Unearned Revenue | - | 1.29 | 0.63 | -255.59 | -151.82 | 407.7 |
Changes in Other Operating Activities | 39.35 | 56.13 | 30.29 | 12.71 | -4.49 | -109.75 |
Operating Cash Flow | 1,285 | 1,128 | -140.63 | -1,157 | -1,497 | -1,299 |
Operating Cash Flow Growth | 505.99% | - | - | - | - | - |
Capital Expenditures | -170.22 | -185.84 | -492.66 | -561.9 | -325.43 | -262.94 |
Purchases of Intangible Assets | -10.69 | -80.69 | -36.47 | -34.37 | -143.67 | -51.91 |
Purchases of Investments | - | -11.83 | -19.01 | -14.9 | -15.91 | -2,191 |
Proceeds from Sale of Investments | 1.67 | 3.45 | 2.66 | 673.24 | 1,564 | 3,147 |
Other Investing Activities | 1.35 | -1.24 | -2.86 | -2.08 | -1.49 | - |
Investing Cash Flow | -199.72 | -276.16 | -548.35 | 60 | 1,077 | 640.66 |
Short-Term Debt Issued | 211.88 | 233.68 | 868.27 | 661.53 | 313.77 | 406.45 |
Short-Term Debt Repaid | -871.86 | -1,045 | -704.22 | -309.58 | -417.08 | -321.75 |
Net Short-Term Debt Issued (Repaid) | -659.98 | -811.11 | 164.05 | 351.95 | -103.31 | 84.7 |
Long-Term Debt Issued | - | 850.59 | 9.05 | 22.5 | 37.37 | 16.84 |
Long-Term Debt Repaid | -39.11 | -39.72 | -28.03 | -13.69 | - | - |
Net Long-Term Debt Issued (Repaid) | -39.11 | 810.86 | -18.98 | 8.81 | 37.37 | 16.84 |
Issuance of Common Stock | 156.8 | 196.28 | 45.37 | 55.71 | 46.96 | 3,535 |
Net Common Stock Issued (Repurchased) | 156.8 | 196.28 | 45.37 | 55.71 | 46.96 | 3,535 |
Other Financing Activities | -15.35 | 863.41 | 3 | - | - | - |
Financing Cash Flow | 1,162 | 1,059 | 193.45 | 416.48 | -18.97 | 3,637 |
Effect of Exchange Rate Changes on Cash and Cash Equivalents | 75.86 | 60.02 | -51.71 | -8.08 | -69.38 | 14.04 |
Net Cash Flow | 2,323 | 1,971 | -547.24 | -689.05 | -507.85 | 2,993 |
Free Cash Flow | 1,115 | 941.74 | -633.29 | -1,719 | -1,822 | -1,562 |
Free Cash Flow Growth | 18.36% | - | - | - | - | - |
FCF Margin | 19.64% | 17.63% | -16.62% | -69.93% | -128.68% | -132.76% |
Free Cash Flow Per Share | 9.73 | 8.30 | -6.01 | -16.47 | -17.67 | -16.83 |
Levered Free Cash Flow | 80.62 | 598.39 | -648.34 | -1,177 | -2,501 | -1,268 |
Unlevered Free Cash Flow | 803.79 | 619.48 | -835.99 | -1,946 | -2,260 | -1,370 |